Increased CD70 expression is associated with clinical resistance to cisplatin-based chemotherapy and poor survival in advanced ovarian carcinomas

BACKGROUND: CD70 has been regarded as a novel potential therapeutic target for multiple cancers. In this study, we characterized the expression of the CD70 protein in ovarian carcinomas and assessed its clinical-pathological prognostic value. MATERIALS AND METHODS: The expression of CD70 in advanced...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Naifu, Sheng, Xiugui, Liu, Yi, Zhang, Xiaoling, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681401/
https://www.ncbi.nlm.nih.gov/pubmed/23776334
http://dx.doi.org/10.2147/OTT.S44445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681401/
https://www.ncbi.nlm.nih.gov/pubmed/23776334
http://dx.doi.org/10.2147/OTT.S44445

Ejemplares similares